What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Immunology, Antibody, Monoclonal antibody, Cancer research and Molecular biology.
In his study, Isotype is strongly linked to Cytotoxicity, which falls under the umbrella field of Antibody.
His Monoclonal antibody research includes elements of Glycoprotein, Ganglioside, Neuroblastoma and Antigen.
In Antigen, Ralph A. Reisfeld works on issues like Biochemistry, which are connected to Chromatography.
His Cancer research research incorporates elements of Cancer and Metastasis.
His biological study spans a wide range of topics, including Proteoglycan, Chondroitin sulfate proteoglycan, Cell culture and Cell adhesion.
His most cited work include:
- Disk Electrophoresis of Basic Proteins and Peptides on Polyacrylamide Gels (2626 citations)
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels (2202 citations)
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma (1041 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Antigen, Molecular biology, Antibody and Cancer research.
His Immunology study frequently draws connections between related disciplines such as Melanoma.
His Antigen research includes themes of Cytotoxic T cell, Pan-T antigens and Biochemistry, Glycoprotein.
The study incorporates disciplines such as Cytolysis, Cytokine and Fusion protein in addition to Antibody.
His Cancer research research incorporates themes from Cancer, Metastasis and In vivo.
His Immunotherapy research is multidisciplinary, relying on both T cell and Neuroblastoma.
He most often published in these fields:
- Immunology (34.50%)
- Antigen (33.47%)
- Molecular biology (29.77%)
What were the highlights of his more recent work (between 2001-2019)?
- Cancer research (23.82%)
- Immunology (34.50%)
- Immunotherapy (17.25%)
In recent papers he was focusing on the following fields of study:
Ralph A. Reisfeld mainly focuses on Cancer research, Immunology, Immunotherapy, DNA vaccination and Angiogenesis.
His study in Cancer research is interdisciplinary in nature, drawing from both Cancer, Metastasis and Cytotoxic T cell.
His research ties Neuroblastoma and Immunology together.
The Neuroblastoma study combines topics in areas such as Oncology, Phases of clinical research, Internal medicine, Interleukin 2 and Monoclonal antibody.
His work on Neovascularization as part of general Angiogenesis research is often related to Kinase insert domain receptor and Endoglin, thus linking different fields of science.
His study looks at the relationship between Antigen and topics such as Antibody, which overlap with Fusion protein.
Between 2001 and 2019, his most popular works were:
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma (1041 citations)
- Tumor Regression by Targeted Gene Delivery to the Neovasculature (775 citations)
- Antibody targeted drugs as cancer therapeutics (636 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Cancer research, Immunology, Angiogenesis, Metastasis and Immunotherapy.
His Cancer research research includes themes of Legumain and Carcinogenesis, Cancer, Breast cancer.
The study incorporates disciplines such as Receptor, Melanoma, Neuroblastoma and In vivo in addition to Immunology.
His Neuroblastoma study incorporates themes from Oncology, Natural killer cell, Internal medicine, Interleukin 2 and Monoclonal antibody.
He has researched Interleukin 2 in several fields, including Antibody and Ratón.
His work carried out in the field of Angiogenesis brings together such families of science as Cytotoxic T cell, Endothelium, Radiation therapy and DNA vaccination.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
